The interim phase III trial results are in: Oxford University’s COVID-19 vaccine is effective. Find out more about this story: ttps://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine
Transcript
The Oxford Covid-19 vaccine is highly effective, according to new data released today.
In trial run on more than 20,000 people across the world, interim data show the vaccine is 70.4% effective, and when participants receive a half dose and then a normal dose, it is 90% effective.
The vaccine is also shown to protect against hospitalization and severe disease.
In partnership with AstraZeneca and other collaborators, we now plan to supply our vaccine globally.
The aim is to supply three billion doses during 2021.
The vaccine can be stored in a fridge rather than a freezer, which makes it easier to deliver and administer in existing healthcare settings.
The next step is to work with regulators around the world, to deliver another tool for humanity against COVID-19 as quickly as possible.
 logo final copy.png)
- Breakthrough in child chronic respiratory diseases - 11th April 2024
- Protein could help detect delayed concussion recovery - 11th April 2024
- New insight into combatting drug-resistant prostate cancer - 11th April 2024
